Corcept Therapeutics
CORT
#2147
Rank
C$10.49 B
Marketcap
$100.20
Share price
3.00%
Change (1 day)
210.93%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2024 (TTM): C$0.84 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is C$0.89 Billion. In 2023 the company made a revenue of C$0.63 Billion an increase over the revenue in the year 2022 that were of C$0.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2024

20102013201620192022$0.2B$0.4B$0.6B$0.8B$1B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) C$0.84 B32.74%
2023 C$0.63 B17.33%
2022 C$0.54 B16.91%
2021 C$0.46 B3.37%
2020 C$0.45 B12.72%
2019 C$0.40 B16.96%
2018 C$0.34 B70.99%
2017 C$0.20 B83.15%
2016 C$0.10 B56.67%
2015 C$69.75 M126.39%
2014 C$30.81 M179.48%
2013 C$11.02 M235.26%
2012 C$3.28 M
2011 N/A
2010 N/A-100%
2009 C$0.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$125.26 B 13,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$67.75 B 7,446.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$71.33 B 7,845.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$58.36 B 6,401.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$85.86 B 9,463.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$90.23 B 9,950.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.42 B-53.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.38 B-57.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.93 B 337.96%๐Ÿ‡บ๐Ÿ‡ธ USA